171 related articles for article (PubMed ID: 27965463)
1. Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature.
Davanian H; Balasiddaiah A; Heymann R; Sundström M; Redenström P; Silfverberg M; Brodin D; Sällberg M; Lindskog S; Kruger Weiner C; Chen M
Oncotarget; 2017 Jan; 8(3):4530-4542. PubMed ID: 27965463
[TBL] [Abstract][Full Text] [Related]
2. Profiling Caenorhabditis elegans non-coding RNA expression with a combined microarray.
He H; Cai L; Skogerbø G; Deng W; Liu T; Zhu X; Wang Y; Jia D; Zhang Z; Tao Y; Zeng H; Aftab MN; Cui Y; Liu G; Chen R
Nucleic Acids Res; 2006; 34(10):2976-83. PubMed ID: 16738136
[TBL] [Abstract][Full Text] [Related]
3. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma.
Kondo S; Ota A; Ono T; Karnan S; Wahiduzzaman M; Hyodo T; Lutfur Rahman M; Ito K; Furuhashi A; Hayashi T; Konishi H; Tsuzuki S; Hosokawa Y; Kazaoka Y
Cancer Med; 2020 Apr; 9(8):2904-2917. PubMed ID: 32096304
[TBL] [Abstract][Full Text] [Related]
5. The Mutational Profile of Unicystic Ameloblastoma.
Heikinheimo K; Huhtala JM; Thiel A; Kurppa KJ; Heikinheimo H; Kovac M; Kragelund C; Warfvinge G; Dawson H; Elenius K; Ristimäki A; Baumhoer D; Morgan PR
J Dent Res; 2019 Jan; 98(1):54-60. PubMed ID: 30216733
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs expression profile in solid and unicystic ameloblastomas.
Setién-Olarra A; Marichalar-Mendia X; Bediaga NG; Aguirre-Echebarria P; Aguirre-Urizar JM; Mosqueda-Taylor A
PLoS One; 2017; 12(10):e0186841. PubMed ID: 29053755
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA KIAA0125 is upregulated in ameloblastomas.
Diniz MG; França JA; Vilas-Boas FAS; de Souza FTA; Calin GA; Gomez RS; de Sousa SF; Gomes CC
Pathol Res Pract; 2019 Mar; 215(3):466-469. PubMed ID: 30595406
[TBL] [Abstract][Full Text] [Related]
8. Progress towards personalized medicine for ameloblastoma.
Gomes CC; Diniz MG; Gomez RS
J Pathol; 2014 Apr; 232(5):488-91. PubMed ID: 24749150
[TBL] [Abstract][Full Text] [Related]
9. Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.
Irizar H; Muñoz-Culla M; Sáenz-Cuesta M; Osorio-Querejeta I; Sepúlveda L; Castillo-Triviño T; Prada A; Lopez de Munain A; Olascoaga J; Otaegui D
BMC Genomics; 2015 Mar; 16(1):250. PubMed ID: 25880556
[TBL] [Abstract][Full Text] [Related]
10. Genetic expression profiling of six odontogenic tumors.
Carinci F; Francioso F; Piattelli A; Rubini C; Fioroni M; Evangelisti R; Arcelli D; Tosi L; Pezzetti F; Carinci P; Volinia S
J Dent Res; 2003 Jul; 82(7):551-7. PubMed ID: 12821718
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of long non-coding RNAs in colorectal cancer: A microarray analysis.
Luo J; Xu L; Jiang Y; Zhuo D; Zhang S; Wu L; Xu H; Huang Y
Oncol Rep; 2016 Apr; 35(4):2035-44. PubMed ID: 26847923
[TBL] [Abstract][Full Text] [Related]
12. Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor.
DeVilliers P; Liu H; Suggs C; Simmons D; Daly B; Zhang S; Raubenheimer E; Larsson A; Wright T
Am J Surg Pathol; 2008 Feb; 32(2):256-60. PubMed ID: 18223328
[TBL] [Abstract][Full Text] [Related]
13. The landscape of genetic alterations in ameloblastomas relates to clinical features.
Gültekin SE; Aziz R; Heydt C; Sengüven B; Zöller J; Safi AF; Kreppel M; Buettner R
Virchows Arch; 2018 May; 472(5):807-814. PubMed ID: 29388014
[TBL] [Abstract][Full Text] [Related]
14. Mutational Signatures in Mandibular Ameloblastoma Correlate with Smoking.
Guan P; Wong SF; Lim JQ; Ng CCY; Soong PL; Sim CQX; Ong CK; Rajasegaran V; Myint SS; Lee JY; Tan HK; Iyer NG; Soo KC; Teh BT; Tay ABG
J Dent Res; 2019 Jun; 98(6):652-658. PubMed ID: 30917298
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of ameloblastoma.
Marín-Márquez C; Kirby J; Hunter KD
J Oral Pathol Med; 2024 May; 53(5):277-293. PubMed ID: 38664938
[TBL] [Abstract][Full Text] [Related]
17. Ameloblastoma-Clinical, radiological, and therapeutic findings.
Kreppel M; Zöller J
Oral Dis; 2018 Mar; 24(1-2):63-66. PubMed ID: 29480593
[TBL] [Abstract][Full Text] [Related]
18. Tuftelin mRNA is expressed in a human ameloblastoma tumor.
Deutsch D; Fermon E; Lustmann J; Dafni L; Mao Z; Leytin V; Palmon A
Connect Tissue Res; 1998; 39(1-3):177-84; discussion 187-94. PubMed ID: 11062999
[TBL] [Abstract][Full Text] [Related]
19. BRAF-V600E expression correlates with ameloblastoma aggressiveness.
Fregnani ER; Perez DE; Paes de Almeida O; Fonseca FP; Soares FA; Castro-Junior G; Alves FA
Histopathology; 2017 Feb; 70(3):473-484. PubMed ID: 27681305
[TBL] [Abstract][Full Text] [Related]
20. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.
Law PT; Qin H; Ching AK; Lai KP; Co NN; He M; Lung RW; Chan AW; Chan TF; Wong N
J Hepatol; 2013 Jun; 58(6):1165-73. PubMed ID: 23376363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
